FR2372827A1 - Composes polycycliques azotes et leurs utilisations therapeutiques comme hypotenseurs - Google Patents

Composes polycycliques azotes et leurs utilisations therapeutiques comme hypotenseurs

Info

Publication number
FR2372827A1
FR2372827A1 FR7736243A FR7736243A FR2372827A1 FR 2372827 A1 FR2372827 A1 FR 2372827A1 FR 7736243 A FR7736243 A FR 7736243A FR 7736243 A FR7736243 A FR 7736243A FR 2372827 A1 FR2372827 A1 FR 2372827A1
Authority
FR
France
Prior art keywords
hypotensors
therapeutic uses
polycyclic compounds
nitrogen
nitrogen polycyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7736243A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of FR2372827A1 publication Critical patent/FR2372827A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Ces composés répondent à la formule :
FR7736243A 1976-12-02 1977-12-01 Composes polycycliques azotes et leurs utilisations therapeutiques comme hypotenseurs Withdrawn FR2372827A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/746,657 US4093726A (en) 1976-12-02 1976-12-02 N-(2-benzimidazolyl)-piperazines

Publications (1)

Publication Number Publication Date
FR2372827A1 true FR2372827A1 (fr) 1978-06-30

Family

ID=25001779

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7736243A Withdrawn FR2372827A1 (fr) 1976-12-02 1977-12-01 Composes polycycliques azotes et leurs utilisations therapeutiques comme hypotenseurs

Country Status (5)

Country Link
US (1) US4093726A (fr)
JP (1) JPS5371088A (fr)
CA (1) CA1086725A (fr)
FR (1) FR2372827A1 (fr)
GB (1) GB1583357A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389765A1 (fr) * 1989-02-10 1990-10-03 Merrell Dow Pharmaceuticals Inc. Antagonistes du calcium
US5106845A (en) * 1990-01-10 1992-04-21 Merrell Dow Pharmaceuticals Inc. Calcium antagonists
EP0548798A1 (fr) * 1991-12-18 1993-06-30 Sanwa Kagaku Kenkyusho Co., Ltd. Agent antiviral

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375470A (en) * 1980-02-04 1983-03-01 American Home Products Corporation 2(1-Piperazinyl)-cycloheptimidazole antihypertensive composition and methods
US4258188A (en) * 1980-02-04 1981-03-24 American Home Products Corporation 2-(1-Piperazinyl)-cycloheptimidazole derivatives
US4333937A (en) * 1980-04-18 1982-06-08 American Home Products Corp. 2-(Piperazinyl)-4-pyrimioinamines
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
JPS59199679A (ja) * 1983-04-27 1984-11-12 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
TW201744B (fr) * 1991-07-02 1993-03-11 Kanebou Textile Co Ltd
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
ES2072193B1 (es) * 1993-05-21 1996-02-16 Espanola Prod Quimicos Nuevos derivados del1-fenilmetil bencimidazol piperacinas.
US6313294B1 (en) 1998-02-04 2001-11-06 Development Center For Biotechnology Process for preparing amides
BR9915013A (pt) 1998-11-03 2001-08-07 Basf Ag Composto, uso dos mesmos, processo para preparar os mesmos, droga, e, método para detecção in vitro para inibidores parp
HUP0200749A3 (en) 1998-11-27 2003-03-28 Basf Ag Substituted benzimidazoles and their use as parp inhibitors and process for their preparation
EP1165084A4 (fr) * 1999-03-03 2002-05-15 Merck & Co Inc Inhibiteurs de prenyl-proteine transferases
AU3390000A (en) * 1999-03-03 2000-09-21 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
GB9914825D0 (en) * 1999-06-24 1999-08-25 Smithkline Beecham Spa Novel compounds
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
US20070004713A1 (en) * 2000-12-07 2007-01-04 Bernard Barlaam Therapeutic benimidazole compounds
JP2006505570A (ja) * 2002-10-17 2006-02-16 アムジエン・インコーポレーテツド ベンズイミダゾール誘導体およびそれのバニロイド受容体リガンドとしての使用
AU2006235759B2 (en) * 2005-04-06 2011-07-28 Msd K.K. 1,4-substituted piperazine derivative
TWI375673B (en) * 2005-04-11 2012-11-01 Abbott Lab 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
US7728026B2 (en) * 2005-04-11 2010-06-01 Abbott Laboratories, Inc. 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
EP1957477B1 (fr) * 2005-09-29 2011-12-07 Abbott Laboratories 1h-benzimidazole-4-carboxamides a substitution phenyle en position 2, utilises comme inhibiteurs de la parp
TW200736229A (en) * 2005-11-15 2007-10-01 Abbott Lab Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
ES2462240T3 (es) * 2006-02-28 2014-05-22 Dart Neuroscience (Cayman) Ltd Piperazinas terapéuticas como inhibidores de PDE4
US8927546B2 (en) * 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
US8685961B2 (en) * 2006-03-29 2014-04-01 Merck Sharp & Dohme Corp. Diazepan orexin receptor antagonists
ATE553104T1 (de) * 2006-05-02 2012-04-15 Abbott Lab Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer
US8067613B2 (en) * 2007-07-16 2011-11-29 Abbott Laboratories Benzimidazole poly(ADP ribose)polymerase inhibitors
WO2010083199A1 (fr) * 2009-01-19 2010-07-22 Abbott Laboratories Inhibiteurs benzthiazole de la poly(adp-ribose)polymérase
FR3000065A1 (fr) * 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes
CA3066361A1 (fr) 2017-06-07 2018-12-13 Shifamed Holdings, Llc Dispositifs de deplacement de fluide intravasculaire, systemes et procedes d'utilisation
US11511103B2 (en) 2017-11-13 2022-11-29 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
WO2019152875A1 (fr) 2018-02-01 2019-08-08 Shifamed Holdings, Llc Pompes à sang intravasculaires et méthodes d'utilisation et procédés de fabrication
JP2022540616A (ja) 2019-07-12 2022-09-16 シファメド・ホールディングス・エルエルシー 血管内血液ポンプならびに製造および使用の方法
WO2021016372A1 (fr) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Pompes à sang intravasculaires à entretoises et procédés d'utilisation et de fabrication
WO2021062265A1 (fr) 2019-09-25 2021-04-01 Shifamed Holdings, Llc Dispositifs et systèmes de pompes à sang intravasculaires et leurs procédés d'utilisation et de commande
WO2021062270A1 (fr) 2019-09-25 2021-04-01 Shifamed Holdings, Llc Pompes à sang de cathéter et boîtiers de pompe pliables

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50126682A (fr) * 1974-03-25 1975-10-04

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574218A (en) * 1969-08-11 1971-04-06 Egyt Gyogyszervegyeszeti Gyar 2-aryl- or aralkyl-substituted benzazole derivatives
BE787059A (fr) * 1971-08-03 1973-02-01 Wander Ag Dr A Nouveaux derives du thiazole, leur preparation et leur application comme medicaments
DE2436883C2 (de) * 1974-07-29 1985-08-22 Schering AG, 1000 Berlin und 4709 Bergkamen Benzimidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50126682A (fr) * 1974-03-25 1975-10-04

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1976 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389765A1 (fr) * 1989-02-10 1990-10-03 Merrell Dow Pharmaceuticals Inc. Antagonistes du calcium
US5106845A (en) * 1990-01-10 1992-04-21 Merrell Dow Pharmaceuticals Inc. Calcium antagonists
EP0548798A1 (fr) * 1991-12-18 1993-06-30 Sanwa Kagaku Kenkyusho Co., Ltd. Agent antiviral

Also Published As

Publication number Publication date
JPS5371088A (en) 1978-06-24
GB1583357A (en) 1981-01-28
US4093726A (en) 1978-06-06
CA1086725A (fr) 1980-09-30

Similar Documents

Publication Publication Date Title
FR2372827A1 (fr) Composes polycycliques azotes et leurs utilisations therapeutiques comme hypotenseurs
FR2453145A1 (fr)
FR2366278A1 (fr) Esters et amides maloniques de piperidyle-4 utilisables comme stabilisants de matieres plastiques
FR2359115A1 (fr) Derives tetraalkyles de bis-cyclohexylamines et leur preparation
FR2392978A2 (fr) Naphtalimides substitues utilisables comme medicaments
FR2392007A1 (fr) 3,3,3-triarylalkyl-4-phenylalkyl-4-hydroxy-piperidines, leurs derives, leur preparation et leur utilisation comme antidiarrheiques et analgesiques
FR2387192A1 (fr) Conducteurs cationiques amorphes du lithium
FR2390960A1 (fr) Composes steroliques 15-oxygenes, ainsi que leur application dans l'inhibition de la biosynthese de l'acide mevalonique
FR2430418A1 (fr) Derives halogenomethyles d'a-aminoacides, leur preparation et leurs utilisations therapeutiques
FR2417515A1 (fr) 13-alkylthio (et arylthio)-11,17-epoxy-17-methyl-18-norandrostenes et leurs utilisations therapeutiques
FR2427335A1 (fr) Derives du 5-nitro-imidazole, leur preparation et leurs utilisations comme medicaments antiprotozoaires
FR2422658A1 (fr) Composes piperazinyl-benzoheterocycliques, leur preparation et leurs utilisations therapeutiques
FR2367745A1 (fr) Bis-polyalkyl-piperidines utilisables comme stabilisants de matieres plastiques
FR2361887A1 (fr) Derives du resorcinol, leur preparation et leurs utilisations therapeutiques
FR2377396A1 (fr) Dithienylalkylamines, leur preparation et leurs utilisations therapeutiques
FR2387269A1 (fr) Melanges de colorants azoiques, leur preparation et leurs utilisations
FR2368521A1 (fr) Colorants reactifs
FR2442226A1 (fr) Anilines substituees, leur preparation et leurs utilisations
FR2383163A1 (fr) Derives aromatiques et azotes de l'acetamide, leur preparation et leur utilisation therapeutique comme anti-arythmiques
FR2372164A1 (fr) Pyridobenzodiazepinones, leur preparation et leurs utilisations therapeutiques
FR2387215A1 (fr) 4-alcoylthio-2-trifluoromethylalcanesulfonanilides et leurs derives
FR2381030A1 (fr) Phenylaminomethyl-2 imidazolines et leur preparation
FR2426690A2 (fr) Composes de rifamycine
FR2375223A1 (fr) 1,2,6-thiadiazinones, leur preparation et leurs utilisations
FR2372792A1 (fr) Aminoalcoxybenzenes, leur preparation et leurs utilisations therapeutiques

Legal Events

Date Code Title Description
ST Notification of lapse